LY2157299 5mg 5mg | Purity Not Available
Adooq Bioscience
LY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageLY2157299 is an orally active transforming growth factor beta receptor (TGF-??R) kinase inhibitor.
More Information Supplier PageZM-447439 is a potein, selective ATP-competitive Aurora B kinase inhibitor with an IC50 of 50 nM, 1 ??M and 250 nM for Aurora B, A and C, respectively.
More Information Supplier PageZibotentan (ZD4054)is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM).
More Information Supplier PageZibotentan (ZD4054)is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM).
More Information Supplier PageZibotentan (ZD4054)is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM).
More Information Supplier PageZibotentan (ZD4054)is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM).
More Information Supplier PageZibotentan (ZD4054)is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM).
More Information Supplier Page